HUMA · Humacyte, Inc.
$0.60
+0.05 (+9.96%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will not have sufficient liquidity to fund our operations beyond one year from the issuance of these interim financial statements if we are unable to generate sufficient cash flows from commercial sales on a timely basis and/or obtain additional capital. These factors raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$168.01M
Shares
277.80M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-12 | Humacyte Second Quarter 2026 Financial Results and Corporate Update | Event |
| 2026-08-12 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-13 | Humacyte First Quarter 2026 Financial Results and Corporate Update | Event |
| 2026-04-28 | Humacyte Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients | Event |
| 2026-03-27 | Humacyte Fourth Quarter and Full Year 2025 Financial Results and Corporate Update | Event |
Source: https://humacyte.com/investors/
Key facts
CIK
1818382
CUSIP
44486Q103
13F (30d)
155 filings
152 filers
Visit website
Investor relations